Geron CorpNASDAQ:GERN
- LAST PRICE4.5900
- TODAY'S CHANGE (%)0.7000 (17.9949%)
- Bid / Lots4.6000/ 10
- Ask / Lots4.6100/ 83
- Open / Previous Close4.4600 / 3.8900
- Day Range
- 52 Week Range
- Volume98,937,923
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GERN |
|---|---|---|
| 09:32 ET | 2906993 | 4.525 |
| 09:34 ET | 947475 | 4.56 |
| 09:36 ET | 1224296 | 4.6499 |
| 09:38 ET | 1184534 | 4.82 |
| 09:39 ET | 1415192 | 4.8931 |
| 09:41 ET | 2839532 | 5.1001 |
| 09:43 ET | 2087960 | 4.97 |
| 09:45 ET | 1407065 | 4.9999 |
| 09:48 ET | 1380631 | 4.8885 |
| 09:50 ET | 2181608 | 4.975 |
| 09:52 ET | 667136 | 4.9106 |
| 09:54 ET | 1196462 | 4.84 |
| 09:56 ET | 1270029 | 4.89 |
| 09:57 ET | 780561 | 4.8599 |
| 09:59 ET | 660571 | 4.89 |
| 10:01 ET | 810517 | 4.8788 |
| 10:03 ET | 376318 | 4.865 |
| 10:06 ET | 1061393 | 4.96 |
| 10:08 ET | 491110 | 4.885 |
| 10:10 ET | 1184996 | 4.7299 |
| 10:12 ET | 543060 | 4.715 |
| 10:14 ET | 453546 | 4.665 |
| 10:15 ET | 291241 | 4.6899 |
| 10:17 ET | 360391 | 4.71 |
| 10:19 ET | 199189 | 4.74 |
| 10:21 ET | 309358 | 4.73 |
| 10:24 ET | 379301 | 4.6912 |
| 10:26 ET | 232212 | 4.725 |
| 10:28 ET | 302172 | 4.6701 |
| 10:30 ET | 575748 | 4.645 |
| 10:32 ET | 301530 | 4.6412 |
| 10:33 ET | 1152775 | 4.535 |
| 10:35 ET | 962094 | 4.4946 |
| 10:37 ET | 747469 | 4.605 |
| 10:39 ET | 805878 | 4.5488 |
| 10:42 ET | 297964 | 4.615 |
| 10:44 ET | 622032 | 4.6715 |
| 10:46 ET | 833084 | 4.7149 |
| 10:48 ET | 804582 | 4.7088 |
| 10:50 ET | 397061 | 4.6212 |
| 10:51 ET | 388160 | 4.675 |
| 10:53 ET | 308939 | 4.7 |
| 10:55 ET | 219906 | 4.695 |
| 10:57 ET | 352688 | 4.595 |
| 11:00 ET | 162195 | 4.575 |
| 11:02 ET | 172086 | 4.5913 |
| 11:04 ET | 268542 | 4.62 |
| 11:06 ET | 584746 | 4.65 |
| 11:08 ET | 723891 | 4.54 |
| 11:09 ET | 346378 | 4.545 |
| 11:11 ET | 163465 | 4.585 |
| 11:13 ET | 111540 | 4.6 |
| 11:15 ET | 254793 | 4.655 |
| 11:18 ET | 215529 | 4.67 |
| 11:20 ET | 225688 | 4.665 |
| 11:22 ET | 248102 | 4.665 |
| 11:24 ET | 363295 | 4.685 |
| 11:26 ET | 388955 | 4.685 |
| 11:27 ET | 144954 | 4.665 |
| 11:29 ET | 277623 | 4.655 |
| 11:31 ET | 331854 | 4.595 |
| 11:33 ET | 289409 | 4.65 |
| 11:36 ET | 178062 | 4.655 |
| 11:38 ET | 70543 | 4.655 |
| 11:40 ET | 324378 | 4.6601 |
| 11:42 ET | 915531 | 4.82 |
| 11:44 ET | 1058216 | 4.765 |
| 11:45 ET | 726992 | 4.675 |
| 11:47 ET | 236790 | 4.685 |
| 11:49 ET | 341047 | 4.675 |
| 11:51 ET | 246459 | 4.735 |
| 11:54 ET | 166271 | 4.72 |
| 11:56 ET | 141543 | 4.7012 |
| 11:58 ET | 200156 | 4.765 |
| 12:00 ET | 98458 | 4.72 |
| 12:02 ET | 156916 | 4.72 |
| 12:03 ET | 246474 | 4.72 |
| 12:05 ET | 341123 | 4.735 |
| 12:07 ET | 512900 | 4.7 |
| 12:09 ET | 340813 | 4.695 |
| 12:12 ET | 179192 | 4.6699 |
| 12:14 ET | 219920 | 4.61 |
| 12:16 ET | 190098 | 4.66 |
| 12:18 ET | 202917 | 4.64 |
| 12:20 ET | 153780 | 4.68 |
| 12:21 ET | 176061 | 4.705 |
| 12:23 ET | 135455 | 4.7 |
| 12:25 ET | 179866 | 4.715 |
| 12:27 ET | 184280 | 4.705 |
| 12:30 ET | 98703 | 4.7 |
| 12:32 ET | 481798 | 4.69 |
| 12:34 ET | 147216 | 4.725 |
| 12:36 ET | 457409 | 4.7 |
| 12:38 ET | 361315 | 4.6492 |
| 12:39 ET | 131175 | 4.695 |
| 12:41 ET | 159757 | 4.695 |
| 12:43 ET | 111612 | 4.685 |
| 12:45 ET | 163393 | 4.7 |
| 12:48 ET | 174894 | 4.695 |
| 12:50 ET | 195558 | 4.6997 |
| 12:52 ET | 277187 | 4.685 |
| 12:54 ET | 241551 | 4.675 |
| 12:56 ET | 165416 | 4.685 |
| 12:57 ET | 107600 | 4.695 |
| 12:59 ET | 241252 | 4.695 |
| 01:01 ET | 98340 | 4.69 |
| 01:03 ET | 142337 | 4.695 |
| 01:06 ET | 141057 | 4.68 |
| 01:08 ET | 59964 | 4.695 |
| 01:10 ET | 186150 | 4.687 |
| 01:12 ET | 77451 | 4.685 |
| 01:14 ET | 207005 | 4.695 |
| 01:15 ET | 104833 | 4.67 |
| 01:17 ET | 55849 | 4.6788 |
| 01:19 ET | 193017 | 4.695 |
| 01:21 ET | 66312 | 4.7 |
| 01:24 ET | 191616 | 4.685 |
| 01:26 ET | 39687 | 4.685 |
| 01:28 ET | 297737 | 4.695 |
| 01:30 ET | 79402 | 4.685 |
| 01:32 ET | 119687 | 4.695 |
| 01:33 ET | 71220 | 4.69 |
| 01:35 ET | 225691 | 4.685 |
| 01:37 ET | 280572 | 4.675 |
| 01:39 ET | 350103 | 4.675 |
| 01:42 ET | 61759 | 4.675 |
| 01:44 ET | 124275 | 4.7093 |
| 01:46 ET | 160693 | 4.715 |
| 01:48 ET | 112570 | 4.69 |
| 01:50 ET | 62315 | 4.6933 |
| 01:51 ET | 132888 | 4.682 |
| 01:53 ET | 85591 | 4.685 |
| 01:55 ET | 98248 | 4.685 |
| 01:57 ET | 60481 | 4.685 |
| 02:00 ET | 130973 | 4.655 |
| 02:02 ET | 215243 | 4.615 |
| 02:04 ET | 133900 | 4.635 |
| 02:06 ET | 108631 | 4.615 |
| 02:08 ET | 197324 | 4.605 |
| 02:09 ET | 204380 | 4.575 |
| 02:11 ET | 223714 | 4.575 |
| 02:13 ET | 196905 | 4.585 |
| 02:15 ET | 248055 | 4.575 |
| 02:18 ET | 142413 | 4.615 |
| 02:20 ET | 186116 | 4.605 |
| 02:22 ET | 166370 | 4.625 |
| 02:24 ET | 135969 | 4.635 |
| 02:26 ET | 147144 | 4.64 |
| 02:27 ET | 233226 | 4.615 |
| 02:29 ET | 98850 | 4.6202 |
| 02:31 ET | 200562 | 4.635 |
| 02:33 ET | 59215 | 4.635 |
| 02:36 ET | 143819 | 4.635 |
| 02:38 ET | 244522 | 4.665 |
| 02:40 ET | 256796 | 4.645 |
| 02:42 ET | 90051 | 4.635 |
| 02:44 ET | 146501 | 4.635 |
| 02:45 ET | 170426 | 4.615 |
| 02:47 ET | 469717 | 4.62 |
| 02:49 ET | 97842 | 4.625 |
| 02:51 ET | 332746 | 4.635 |
| 02:54 ET | 91685 | 4.635 |
| 02:56 ET | 154295 | 4.65 |
| 02:58 ET | 542693 | 4.675 |
| 03:00 ET | 119807 | 4.6699 |
| 03:02 ET | 412700 | 4.7499 |
| 03:03 ET | 418977 | 4.755 |
| 03:05 ET | 273462 | 4.765 |
| 03:07 ET | 703853 | 4.665 |
| 03:09 ET | 328950 | 4.655 |
| 03:12 ET | 192702 | 4.65 |
| 03:14 ET | 100152 | 4.6698 |
| 03:16 ET | 595849 | 4.665 |
| 03:18 ET | 152550 | 4.6583 |
| 03:20 ET | 368721 | 4.645 |
| 03:21 ET | 256076 | 4.615 |
| 03:23 ET | 49137 | 4.615 |
| 03:25 ET | 264716 | 4.615 |
| 03:27 ET | 76298 | 4.625 |
| 03:30 ET | 172172 | 4.595 |
| 03:32 ET | 257940 | 4.6 |
| 03:34 ET | 166827 | 4.58 |
| 03:36 ET | 248790 | 4.565 |
| 03:38 ET | 172673 | 4.564 |
| 03:39 ET | 543790 | 4.575 |
| 03:41 ET | 281628 | 4.565 |
| 03:43 ET | 372707 | 4.535 |
| 03:45 ET | 420666 | 4.535 |
| 03:48 ET | 303862 | 4.53 |
| 03:50 ET | 561546 | 4.515 |
| 03:52 ET | 593865 | 4.565 |
| 03:54 ET | 567720 | 4.52 |
| 03:56 ET | 1017507 | 4.58 |
| 03:57 ET | 1015470 | 4.595 |
| 03:59 ET | 1879762 | 4.59 |
Jun 7, 2024
DJ Geron Is Maintained at Buy by Needham, from 9:55AM ET on Friday Jun 07, 2024 by Dow Jones
9:55AM ET on Friday Jun 07, 2024 by Dow JonesDJ Geron Price Target Maintained With a $7.00/Share by Wedbush, from 8:30AM ET on Friday Jun 07, 2024 by Dow Jones
8:30AM ET on Friday Jun 07, 2024 by Dow JonesDJ Geron Shares Rise Premarket on FDA Nod for Rytelo, from 6:04AM ET on Friday Jun 07, 2024 by Dow Jones
6:04AM ET on Friday Jun 07, 2024 by Dow Jones
Jun 6, 2024
May 16, 2024
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Thursday May 16, 2024 by Dow Jones
4:30PM ET on Thursday May 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Geron Corp | 2.4B | -13.3x | --- |
CG Oncology Inc | 2.3B | -31.0x | --- |
Iovance Biotherapeutics Inc | 2.3B | -4.3x | --- |
Structure Therapeutics Inc | 2.5B | -22.9x | --- |
Janux Therapeutics Inc | 2.5B | -36.1x | --- |
Apogee Therapeutics Inc | 2.6B | -20.4x | --- |
Company Information
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Contact Information
- Headquarters
- 919 East Hillsdale Boulevard, Suite 250FOSTER CITY, CA, United States 94404
- Phone
- 650-473-7700
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- John Scarlett
- Chief Financial Officer, Executive Vice President - Finance, Treasurer
- Michelle Robertson
- Executive Vice President, Chief Operating Officer
- Andrew Grethlein
- Chief People Officer, Senior Vice President
- Shannon Odam
- Executive Vice President, Chief Legal Officer, Secretary
- Scott Samuels
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
|---|---|
Revenue (TTM) | $520.0K |
Shares Outstanding | 593.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-0.35 |
Book Value | $0.46 |
P/E Ratio | -13.3x |
Price/Sales (TTM) | 4,562.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40,381.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
